"Intuitive Surgical's Next-Gen da Vinci 5 Cleared by FDA, Surgeries Boost Demand"
TL;DR
Intuitive Surgical has submitted for FDA clearance of its next-generation da Vinci 5 multiport surgical robot, with hopes for a 2024 launch. The company reported strong Q4 results, with revenue up 17% year-over-year. The da Vinci 5 will join Intuitive’s existing robotic surgical system portfolio, and the company is also in discussions with regulators in Japan and South Korea. Intuitive is gearing up for da Vinci 5 manufacturing and promises more details about its features and benefits after FDA clearance.
Topics:businesshealthcare-technology#da-vinci-5#fda-clearance#healthcare-technology#intuitive-surgical#surgical-robot
- Intuitive seeks FDA clearance for its next-gen da Vinci 5 Mass Device
- ISRG Stock Rallies After Beating Fourth-Quarter Earnings Views Investor's Business Daily
- Here's What Key Metrics Tell Us About Intuitive Surgical, Inc. (ISRG) Q4 Earnings Yahoo Finance
- Intuitive Surgical, Inc. (ISRG) Q4 2023 Earnings Call Transcript Seeking Alpha
- Intuitive beats estimates as rebound in surgeries boost demand for its robots Reuters
Want the full story? Read the original reporting
Read on Mass Device